Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | WRN | Q14191 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8707556 | 0.87 | ALDH1A1 (0.35) | ALDH1A1TSHRNAAATDP1FFAR3 | |
| SCHEMBL1563399 | 0.85 | TSHR (0.55) | ALDH1A1TSHRTDP1MGAMGAA | |
| SCHEMBL6836768 | 0.83 | ALDH1A1 (0.32) | ALDH1A1NAAA | |
| SCHEMBL27951381 | 0.81 | FDPS (0.38) | ALDH1A1TDP1BLM | |
| SCHEMBL27909864 | 0.81 | CTSA (0.36) | ALDH1A1TDP1 | |
| SCHEMBL17956591 | 0.81 | CYP3A4 (0.43) | ALDH1A1TSHRNAAAKMT2ACYP3A4 | |
| SCHEMBL11506056 | 0.80 | ALDH1A1 (0.38) | ALDH1A1TSHRNAAATDP1FFAR3 | |
| SCHEMBL28198850 | 0.80 | ALDH1A1 (0.38) | ALDH1A1NAAATDP1FFAR3MGAM | |
| SCHEMBL414813 | 0.80 | — | — | |
| SCHEMBL28822581 | 0.79 | TSHR (0.48) | ALDH1A1TSHRTDP1MGAMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118599493-A | Phase-change flame-retardant heat-conducting microcapsule and preparation method thereof | 天津大学 | 2024-09-06 | — | — | CN | claimed |
| CN-112353827-B | Application of VSM in preparation of medicines for treating rhabdomyosarcoma | 山东省分析测试中心 | 2022-05-27 | — | — | CN | claimed |
| CN-112353827-A | Application of VSM in preparation of medicines for treating rhabdomyosarcoma | 山东省分析测试中心 | 2021-02-12 | — | — | CN | claimed |
| WO-2016097289-A1 | ENZYMATIC PRODUCTION OF ACRYLYL-COA OR ETHYLENE FROM GLYCEROL | GLOBAL BIOENERGIES (FR) | 2016-06-23 | — | — | WO | claimed |
| US-9163868-B2 | Methods and components for thermal energy storage | TECHNOLOGY FOR RENEWABLE ENERGY SYSTEMS (TFRES) BVBA (BE) | 2015-10-20 | — | — | US | claimed |
| EP-2668459-A1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | Technology For Renewable Energy Systems (TFRES) BV (BE) | 2013-12-04 | — | — | EP | claimed |
| US-20130306268-A1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | TECHNOLOGY FOR RENEWABLE ENERGY SYSTEMS (TFRES) BVBA (BE) | 2013-11-21 | — | — | US | claimed |
| WO-2012101110-A1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | TECHNOLOGY FOR RENEWABLE ENERGY SYSTEMS (TFRES) BVBA (BE) | 2012-08-02 | — | — | WO | claimed |
| US-20260022409-A1 | PANTOIC ACID-PRODUCING RECOMBINANT MICROORGANISM AND USE THEREOF | ANHUI HUAHENG BIOTECHNOLOGY CO LTD (CN) | 2026-01-22 | — | — | US | disclosed |
| EP-4674950-A1 | RECOMBINANT MICROORGANISM FOR PRODUCING PANTOIC ACID AND USE THEREOF | Anhui Huaheng Biotechnology Co., Ltd. (CN) | 2026-01-07 | — | — | EP | disclosed |
| CN-119954960-A | Fusion protein for promoting synthesis of 1, 3-propanediol and application thereof | 中国科学院天津工业生物技术研究所 | 2025-05-09 | — | — | CN | disclosed |
| US-20250122488-A1 | ENGINEERED ADENYLATE KINASE VARIANTS | CODEXIS, INC. | 2025-04-17 | — | — | US | disclosed |
| WO-2025081095-A1 | ENGINEERED ACETATE KINASE VARIANTS | CODEXIS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-20250122487-A1 | ENGINEERED ACETATE KINASE VARIANTS | CODEXIS, INC. | 2025-04-17 | — | — | US | disclosed |
| EP-1731604-A1 | PROCESS FOR PRODUCING 1,3-PROPANEDIOL AND/OR 3-HYDROXYPROPIONIC ACID | NIPPON SHOKUBAI KAGAKU KOGYO CO. LTD. (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-6218101-B1 | CONTACTING SOLUTION WITH ENZYME WHICH CONVERTS CRYOPROTECTANT TO PRODUCT WHICH IS IMPERMEABLE TO CELLS WHILE MAINTAINING CELL VIABILITY | GENERAL BIOTECHNOLOGY, LLC | 2001-04-17 | — | — | US | disclosed |
| EP-0385486-B1 | Process for producing fructose-1,6-diphosphate | UNITIKA LTD (JP) | 1994-06-22 | — | — | EP | disclosed |
| US-5094947-A | PROCESS FOR PRODUCING FRUCTOSE-1,6-DIPHOSPHATE | UNITIKA, LTD. (JP) | 1992-03-10 | — | — | US | disclosed |
| EP-0385486-A1 | Process for producing fructose-1,6-diphosphate | UNITIKA LTD. (JP) | 1990-09-05 | — | — | EP | disclosed |
| US-4701285-A | Acyl phosphate salts and their use | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1987-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022409-A1 | PANTOIC ACID-PRODUCING RECOMBINANT MICROORGANISM AND USE THEREOF | COASY, PGAM1, ME1 | ALDH1A1 549/4885TSHR 2460/4885NAAA 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.